<?xml version="1.0" encoding="UTF-8"?>
<p>Regulatory agencies (e.g., FDA, EMA) consider excipient sulphites safe. However, they present risks and possible fatal side effects derived of their use. One of the most common cases occurs in asthmatic patients, who may develop severe bronchospasm if they take medicines containing sulphites in their formulation [
 <xref rid="B29-pharmaceutics-13-00387" ref-type="bibr">29</xref>].
</p>
